News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
743,453 Results
Type
Article (45655)
Company Profile (269)
Press Release (697514)
Multimedia
Podcasts (100)
Webinars (22)
Section
Business (207369)
Career Advice (2324)
Deals (35949)
Drug Delivery (133)
Drug Development (83075)
Employer Resources (176)
FDA (16724)
Job Trends (15292)
News (352116)
Policy (33634)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2695)
Accelerated approval (42)
Adcomms (27)
Allergies (166)
Alliances (50210)
ALS (197)
Alzheimer's disease (1754)
Antibody-drug conjugate (ADC) (372)
Approvals (17020)
Artificial intelligence (602)
Autoimmune disease (225)
Automation (50)
Bankruptcy (368)
Best Places to Work (11873)
BIOSECURE Act (21)
Biosimilars (202)
Biotechnology (177)
Bladder cancer (181)
Brain cancer (66)
Breast cancer (689)
Cancer (5368)
Cardiovascular disease (454)
Career advice (1950)
Career pathing (40)
CAR-T (307)
CDC (63)
Celiac Disease (2)
Cell therapy (815)
Cervical cancer (42)
Clinical research (71423)
Collaboration (1898)
Company closure (4)
Compensation (1270)
Complete response letters (72)
COVID-19 (2794)
CRISPR (101)
C-suite (978)
Cystic fibrosis (150)
Data (7091)
Decentralized trials (3)
Denatured (30)
Depression (158)
Dermatology (57)
Diabetes (557)
Diagnostics (6932)
Digital health (52)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (296)
Drug pricing (213)
Drug shortages (30)
Duchenne muscular dystrophy (269)
Earnings (91535)
Editorial (67)
Employer branding (22)
Employer resources (155)
Events (121447)
Executive appointments (1041)
FDA (20152)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1624)
Gene editing (217)
Generative AI (51)
Gene therapy (668)
GLP-1 (1053)
Government (4885)
Grass and pollen (6)
Guidances (396)
Healthcare (19443)
HIV (74)
Huntington's disease (52)
IgA nephropathy (91)
Immunology and inflammation (277)
Immuno-oncology (83)
Indications (157)
Infectious disease (3114)
Inflammatory bowel disease (203)
Inflation Reduction Act (14)
Influenza (130)
Intellectual property (275)
Interviews (391)
IPO (16790)
IRA (53)
Job creations (3736)
Job search strategy (1628)
JPM (61)
Kidney cancer (18)
Labor market (93)
Layoffs (568)
Leadership (34)
Legal (8221)
Liver cancer (98)
Longevity (28)
Lung cancer (722)
Lymphoma (409)
Machine learning (52)
Management (61)
Manufacturing (928)
MASH (179)
Medical device (14055)
Medtech (14132)
Mergers & acquisitions (20320)
Metabolic disorders (1438)
mRNA (182)
Multiple sclerosis (173)
NASH (17)
Neurodegenerative disease (385)
Neuropsychiatric disorders (101)
Neuroscience (3165)
Neurotech (1)
NextGen: Class of 2026 (6774)
Non-profit (4761)
Now hiring (73)
Obesity (681)
Opinion (296)
Ovarian cancer (186)
Pain (229)
Pancreatic cancer (255)
Parkinson's disease (341)
Partnered (33)
Patents (553)
Patient recruitment (589)
Peanut (63)
People (60343)
Pharmaceutical (60)
Pharmacy benefit managers (35)
Phase 1 (22218)
Phase 2 (31396)
Phase 3 (23431)
Pipeline (7123)
Policy (333)
Postmarket research (2707)
Preclinical (9506)
Press Release (65)
Prostate cancer (278)
Psychedelics (49)
Radiopharmaceuticals (309)
Rare diseases (1013)
Real estate (6098)
Recruiting (70)
Regulatory (25478)
Reports (54)
Research institute (2478)
Resumes & cover letters (395)
Rett syndrome (32)
RNA editing (18)
RSV (86)
Schizophrenia (166)
Series A (270)
Series B (201)
Service/supplier (11)
Sickle cell disease (112)
Special edition (25)
Spinal muscular atrophy (166)
Sponsored (45)
Startups (3666)
State (2)
Stomach cancer (19)
Supply chain (118)
Tariffs (91)
The Weekly (68)
Vaccines (1101)
Venture capital (100)
Weight loss (438)
Women's health (109)
Worklife (21)
Date
Last 7 days (647)
Last 30 days (2446)
Last 365 days (30186)
2026 (8056)
2025 (30498)
2024 (35591)
2023 (40489)
2022 (51634)
2021 (56247)
2020 (54897)
2019 (47674)
2018 (35904)
2017 (32717)
2016 (32347)
2015 (38387)
2014 (32129)
2013 (27275)
2012 (29568)
2011 (30223)
2010 (28572)
Location
Africa (798)
Alabama (90)
Alaska (7)
Arizona (335)
Arkansas (13)
Asia (40358)
Australia (6682)
California (12292)
Canada (3523)
China (1246)
Colorado (524)
Connecticut (521)
Delaware (366)
Europe (87928)
Florida (1853)
Georgia (395)
Hawaii (3)
Idaho (63)
Illinois (974)
India (81)
Indiana (560)
Iowa (23)
Japan (488)
Kansas (131)
Kentucky (45)
Louisiana (39)
Maine (73)
Maryland (1496)
Massachusetts (8840)
Michigan (354)
Minnesota (677)
Mississippi (6)
Missouri (141)
Montana (34)
Nebraska (29)
Nevada (136)
New Hampshire (84)
New Jersey (3288)
New Mexico (29)
New York (3253)
North Carolina (1569)
North Dakota (9)
Northern California (6078)
Ohio (365)
Oklahoma (23)
Oregon (41)
Pennsylvania (2489)
Puerto Rico (26)
Rhode Island (51)
South America (1223)
South Carolina (76)
South Dakota (1)
Southern California (4830)
Tennessee (201)
Texas (1937)
United States (43679)
Utah (370)
Vermont (1)
Virginia (293)
Washington D.C. (81)
Washington State (985)
West Virginia (4)
Wisconsin (120)
Wyoming (2)
743,453 Results for "america hears inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Modular Genetics, Inc. joins New American Industrial Alliance to Reindustrialize America
March 5, 2026
·
1 min read
Gene editing
Lilly Leans Into Hearing Loss in $1.12B+ Gene Editing Pact With Seamless
The deal will help bolster Eli Lilly’s growing hearing loss portfolio, which is anchored by the gene therapy AK-OTOF.
January 28, 2026
·
2 min read
·
Tristan Manalac
Press Releases
MedicAlert Foundation, Sickle Cell Disease Association of America, Inc. (SCDAA), and Fulcrum Therapeutics Partner to Accelerate Emergency Department Access to Critical Care Information for People Living with Sickle Cell Disease
March 19, 2026
·
4 min read
Press Releases
Olympus Corporation of the Americas Announces Leadership Change
April 2, 2026
·
3 min read
Press Releases
Tanabe Pharma America Announces Finalization of RADICAVA (edaravone) Transfer to Shionogi
April 2, 2026
·
7 min read
Opinion
Policymakers Must Sustain American Life Sciences Leadership
Maintaining America’s momentum demands that policymakers resist policies that undermine research and development incentives.
February 20, 2026
·
4 min read
·
Dan Leonard
Gene therapy
Gene Therapies for Hearing Loss Strike an Encouraging Note in Embattled Modality
Eli Lilly and Regeneron are leading the push to treat congenital deafness with gene therapies, seeking a piece of a potential billion-dollar market and banking on local delivery and the small amount of drug required to overcome key safety concerns.
March 23, 2026
·
7 min read
·
Tristan Manalac
Press Releases
Cencora to Expand Retina Consultants of America Through Acquisition of EyeSouth Partners’ Retina Business
March 23, 2026
·
6 min read
Press Releases
Ipsen appoints Michelle C. Werner as EVP, President of North America
March 12, 2026
·
7 min read
Press Releases
Tanabe Pharma America to Highlight Research in ALS at 2026 MDA Clinical and Scientific Conference
March 5, 2026
·
6 min read
1 of 74,346
Next
